the hospital research foundation home lottery by owner

Ticket sales have now closed

Seaside Splendour

Win a $3.6 Million luxury life in Henley Beach

Buy early. Win more!

With over 12,400 prizes to win, including the $3.6 Million Grand Prize – this could be the ticket that changes your life!

Incredible prizes on offer with a 1 in 15 chance of winning!

Unlock more with Membership!

Becoming a member is free! You’ll never miss out on a draw and have extra chances to WIN! Simply tick ‘Become a Member’ when you order your tickets.

Win a share in $470,000 CASH!

This could be the ticket to a cash injection! Purchase a ticket in the Cash Calendar Lottery and you could win the First Prize of $400,000 or be one of 7 winners of $10,000!

Win $300,000 cash or 25 years of holidays!

The choice is yours!

The difference you make. See how your support improves life-changing medical research for all South Australians.

Frequently Asked Questions

Who can I contact if I need to make a change to my ticket or I have not received my ticket?

Please contact ticket administrators Deloitte on 08 8407 7212 or [email protected]

How many tickets will be sold in the Home Lottery?

A maximum of 180,000 tickets will be sold.

Who is (or is not) eligible to purchase tickets?

Ticket holders must be 18 years or older. The following persons and immediate family members are ineligible to purchase tickets for themselves or on behalf of any other person: Board members and staff of The Hospital Research Foundation Group and Partners and employees of S.O. Asher Consultants Pty Ltd and Deloitte.

Can I purchase a ticket if I live interstate or overseas?

This lottery is intended for residents of South Australia, however interstate or overseas residents can enter, and we would be very grateful for the support! Whilst the lottery is open to non-resident, interstate and overseas purchasers, the prizes that we have on offer are awarded to winners as presented and cannot be redeemed for cash.

It is important to note, that as this lottery is intended for but not exclusive to residents of South Australia, non-resident & interstate winners are responsible for any additional costs that may be associated with the delivery or transfer of prizes. All vehicle prizes include on-road costs, plus 12 months of South Australian registration.

Where can I order tickets?

You can order tickets online at www.homelottery.com.au , by calling 1300 852 177 at any time or by visiting any of the below locations from Monday 15 January 2024.

The Grand Prize Showhome at 204 East Terrace, Henley Beach will be open from 12:00pm to 5:00pm every Monday, Wednesday, weekends, and public holidays commencing from Monday 22 January 2024.

I cannot afford a $100 ticket. How else can I support?

There are plenty of ways that you can support The Hospital Research Foundation Group and have a chance to win! You can purchase your Home Lottery ticket as part of a syndicate, or you can purchase a ticket in our Cash Calendar Lottery to win a share of $470,000 for just $25, or our Holiday for Life Lottery to win 25 years of holidays or $300,000 cash for just $15!

What does it mean to become a Member?

When you become a Member, your tickets are reserved for each Home Lottery which means you’ll never miss out on a draw, no matter how quickly tickets sell!  Your membership not only ensures that you are a part of every exciting draw in South Australia’s longest running and most trusted Home Lottery – but you’re also automatically entered into exclusive Membership draws, which means extra chances to WIN BIG! 

Members who have a valid ticket in The Hospital Research Foundation Home Lottery and an active Membership to all future Home Lotteries as of midnight on Friday 16 February 2024 will be included in the Early Bird Membership Draw for $100,000 cash.

Members who have a valid ticket in The Hospital Research Foundation Home Lottery and an active Membership to all future Home Lotteries as of midnight on Friday 8 March 2024 will be included in the Bonus Membership Draw for $25,000 cash.

Members who have a valid ticket in The Hospital Research Foundation Home Lottery and an active Membership to all future Home Lotteries as of midnight on Wednesday 27 March 2024 will be included in the Grand Prize Membership Draw for $25,000 cash.

It’s free to join!  Just tick the ‘Become a Member’ box on your order, and we will contact you before each Home Lottery to confirm your order. 

*Please note, the membership draws are exclusive to those who hold Home Lottery tickets as part of their recurring Membership order .

How can I make changes to my Membership or update my credit card details?

Please contact ticket administrators Deloitte on 08 8407 7212 or email [email protected]

What is your refund policy?

All refund requests must be received in writing to [email protected] and will be honoured as long as the payment method has been verified, and the corresponding ticket has not been included in any prize draws.

Are home lottery tickets tax-deductible?

No, tickets purchased are not tax-deductible.

How many prizes are there and what are they?

There are 12,425 prizes, including the $3.6M Grand Prize, $1M cash Early Bird Prize and three Mercedes and Maldives Bonus Prizes. The total value of prizes is $6,746,754.92.

Please click here to download our catalogue of prizes.

Can a ticket purchaser win multiple prizes?

Yes. When you purchase a ticket, you are entered into all subsequent draws! Once a winning ticket is drawn, the winning number is recorded, and the ticket is re-entered in all remaining draws.

Are prizes donated?

No, all prizes are purchased by The Hospital Research Foundation Group .

What is the Grand Prize?

The $3.6 Million Grand Prize is a fully furnished luxury home in Henley Beach, including $250,000 cash.

Click here to view the floor plan.

What is the Early Bird draw?

Buy your tickets early for a chance to become an instant millionaire! One lucky winner will receive $1,000,000 cash.

The Early Bird Prize will be drawn on Friday 23 February 2024 and your tickets will stay in all remaining Home Lottery prize draws for the chance to win!

What are the Bonus draws?

Buy your tickets early and you could be 1 of 3 winners driving away in a Mercedes-Benz GLC 300 and taking a magical 5-night Maldives escape!

The Bonus Prizes will be drawn on Friday 15 March 2024 and your tickets will stay in all remaining Home Lottery prize draws for the chance to win!

Can I visit the Grand Prize home in person?

Yes! The Grand Prize Showhome at 204 East Terrace, Henley Beach will be open from 12:00pm to 5:00pm every Monday, Wednesday, weekend, and public holiday commencing from Monday 22 January 2024.

If I win the home do I have to move in?  How soon do I get the keys?  Can I sell it?

It generally takes a few weeks before the settlement is complete. The winner can move in as soon as the settlement has occurred. The winner does not have to keep the home for a minimum period of time and can choose to sell the home at any point after settlement.

If I win, what do I have to pay for?

As a Hospital Research Foundation Home Lottery Grand Prize winner, you are awarded your new home free and clear of any encumbrances. All fees involved with the property transfer, such as stamp duty and title taxes, will be paid for by The Hospital Research Foundation Group.

This lottery is intended for but not exclusive to residents of South Australia. Non-resident & interstate winners are responsible for any additional costs that may be associated with the delivery or transfer of prizes.

What are my costs after I take possession of my new home?

After you take title of your new home, you would be responsible for the usual costs associated with homeownership.

If I win a prize, can I choose to take cash instead?

All prizes are purchased by The Hospital Research Foundation Group and must be accepted as awarded and cannot be redeemed for cash. Negotiations may occur between the prize supplier and the winner, but The Hospital Research Foundation Group cannot become part of that process.

How can my chances of winning be 1 in 15?

There are 180,000 tickets available and 12,425 prize draws. An actuary has independently verified the calculation to determine the chances of winning. For further information regarding the mathematical equation, please visit homelottery.com.au/chances or email us at  [email protected] .

What is the Cash Calendar Lottery?

The Cash Calendar is a separate lottery. For just $25 you will be entered into 8 cash draws. There is one major prize of $400,000 followed by 7 prizes of $10,000.

Cash Calendar tickets are $25 each, 5 for $60, 8 for $85 or 12 for $110. Ticket sales close at midnight on Wednesday 27 March 2024, and winners will be drawn on Friday 5 April 2024.

A maximum of 180,531 tickets will be sold in the Cash Calendar Lottery.

What is the Holiday for Life Lottery?

The Holiday for Life is a separate lottery. For just $15 you could win a holiday of your choice to the value of $12,000 every year for 25 years or choose to take $300,000 cash instead!

Holiday for Life tickets are $15 each, 5 for $30, 15 for $55 or 30 for $80. Ticket sales close at midnight on Wednesday 27 March 2024, and the winner will be drawn on Friday 5 April 2024.

A maximum of 302,805 tickets will be sold in the Holiday for Life Lottery.

When are the draw dates?

The Early Bird draw is conducted at 7:00am, Friday 23 February 2024 Bonus Prize draws are conducted at 7:00am, Friday 15 March 2024 Final Draws are conducted at 7:00am, Friday 5 April 2024*

*If all tickets are sold before midnight on Friday 8 March 2024, all draws will be conducted early on Friday 15 March 2024.

How and where are the draws conducted?

The draws are conducted using a random number generator under Deloitte’s supervision at their offices, Level 17, 11 Waymouth Street, Adelaide, in accordance with Consumer and Business Services Lottery and Gaming Regulations.

When and where are the winning results published?

The names of all prize winners will be available online at www.homelottery.com.au on either Friday 15 March 2024 or Friday 5 April 2024, depending on the draw date.

The names of the Early Bird Prize Winners will be available online at www.homelottery.com.au on Friday 23 February 2024.

Winners of any prize valued at $250.00 or more will be printed in The Advertiser on Monday 8 April 2024. If all tickets are sold prior to the Bonus Deadline of Friday 8 March 2024, the results will appear in The Advertiser on Monday 18 March 2024.

The names of all Cash Calendar and Holiday for Life winners will be available online at www.homelottery.com.au on Friday 5 April 2024 and in The Advertiser on Monday 8 April 2024.

Will I be notified if I win a prize?

All winners will be notified in writing by Deloitte with instructions on how to claim their prize. If you win the Grand Prize, the Early Bird prize, a Bonus prize, a vehicle, a holiday, a Membership prize, a Cash Calendar or Holiday for Life prize you will also receive a phone call shortly after the draws are conducted.

What happens if I don’t answer my phone?

If your ticket number wins a prize, you have won, regardless of if you miss our call!

If you are a Major Prize Winner, we will continue to attempt to contact you to advise you of your win (see ‘Will I be notified if I win a prize FAQ’ for the list of Major Prizes). If you do not answer your phone, we will attempt to contact you with the additional contact information you provided when you placed your ticket order.

It is important to note that all prizes must be claimed within three months of the applicable draw date.

How long do I have to claim my prize?

All prizes must be claimed within three months of the applicable draw date. We will make multiple attempts to contact winners to ensure they have received their prize.

What happens to unclaimed prizes?

If a prize remains unclaimed after three months and all attempts to contact the winner have been exhausted, The Hospital Research Foundation Group will present the list of unclaimed prizes to the office of Consumer and Business Services and request sanction to use those prizes for further fundraising endeavours within the Foundation.

How are the proceeds of the lottery used?

Proceeds raised from The Hospital Research Foundation Home Lottery are improving treatment and care for every South Australian. Your support of the Home Lottery ensures The Hospital Research Foundation Group can fund world-class medical research, improved care in hospitals and better treatments for our community. Together, we are saving lives.

#TogetherFight

Who can I contact if I no longer wish to receive direct mail, phone calls, emails or SMS relating to the Home Lottery?

Please contact ticket administrators Deloitte on 08 8407 7212 or [email protected] .

CONTACT DETAILS

Phone 08 8407 7212

Email [email protected]

The Hospital Research Foundation Group

Level 1, 62 Woodville Road, Woodville SA 5011

HOME LOTTERY LICENCE M14493

CASH CALENDAR LICENCE M14494

HOLIDAY FOR LIFE LICENCE M14495

• Read Today's Paper

Hospital Research Home Lottery funds lifesaving research at the Royal Adelaide Hospital

BY keeping the human face of medicine in the forefront of its thinking, The Hospital Research Foundation is raising millions for lifesaving research and patient care at the new Royal Adelaide Hospital and public hospitals across Adelaide, supported by the Hospital Research Home Lottery.

F ew people know this better than the researchers and the people seeking life altering treatments from their work.

Professor Jane Andrews and her patient, Rhianna Mummery, 20, are among the many who continue to benefit from THRF’s $1.6 million in funding to set up the new purpose-built Clinical Trials Centre at the RAH.

“This place is essential,” says Prof Andrews, who is acting director and head of the RAH Inflammatory Bowel Disease Service, Gastroenterology and Hepatology.

“If we hadn’t had this centre made available on transition to the new RAH, there would have been a catastrophe, really, for several reasons. Clinical research is and should be an integral part of teaching hospital medicine otherwise ... we’re not serving the teaching hospital role or advancing medicine and we’re not helping patients’ outcomes.

“I think it’s absolutely essential and fantastic that THRF found the financial resources to facilitate that. It’s really not an add-on it’s an essential part of teaching hospital medicine.”

One of many trials Prof Andrews is involved with at the centre is for a new formulation of a drug that treats ulcerative colitis (UC), an inflammatory bowel disease that causes bleeding, abdominal pain and diarrhoea in sufferers. More than 80,000 Australians live with either UC or Crohn’s disease. There is no cure and, if left untreated with drug therapies or surgery, a severe case of the disease can be fatal.

The drug, which has previously been available to the public as an intravenous injection, is being trialled for use as a simpler injection just under the skin — one that patients can safely administer themselves. Prof Andrews says the trial is being conducted simultaneously in medical centres around the world.

Her patient, Rhianna Mummery, is part of the trial, which is going well for her so far.

“I was diagnosed (with UC) in 2007, and I was about 10 years old. I was really skinny and pale and losing a lot of blood in the toilet, so my dad rushed me to the hospital,” Ms Mummery says.

“Then, 18 months later, I finally got diagnosed with UC. I was in hospital for almost three weeks and I got all the treatment I needed and I was pretty much good then. Then about three years later I got inflamed again. Every time I’d get inflamed I’d have steroids, which make me really big (through weight gain).

It wasn’t the best thing as a little kid, especially at school being bullied for the side effects of some medication.

“And you’re always looking out for a toilet or something just in case an accident happens.”

Prof Andrews invited her to join the trial and she jumped at the chance of a more effective treatment with fewer side effects. Now in its third phase after placebo trials last year, the trial is in what’s called the “open-label” phase. “I must have been getting the real drug because it worked and then towards the end of the year I went on the open label, so now I just inject myself every two weeks,” Ms Mummery says.

She urges South Australians to support THRF through donations or buying tickets in the Hospital Research Home Lottery so that lifesaving trials like hers can continue in the RAH’s Clinical Trials Centre. “Do it because it’s a really good cause,” she smiles.

PROFESSOR JOHN BELTRAME

As the Director of Research for the Central Adelaide Local Health Network, leading cardiologist and academic researcher Professor Beltrame gets to keep an eye on all of the research projects at the RAH and The Queen Elizabeth Hospital.

But he also gets to care for patients like Tim Lamming, who is one of about 6000 Australians who suffer from Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA), also known as an “unexplained heart attack” because there are no significant cholesterol blockages in patients’ coronary arteries.

Prof Beltrame hopes to put an end to the suffering of people like Mr Lamming after receiving the inaugural Basil Hetzel Translational Grant through THRF in 2017. With his team, he is doing pioneering research into the causes and treatment of MINOCA.

“This has given us a tremendous opportunity to advance (treatment of) this condition,” he says. “Most patients who have a heart attack have significant cholesterol blockages and that enable us to do (standard) treatments. In about 5 to 10 per cent of patients, they don’t have these blockages so we can’t do these kind of treatments.

“MINOCA was first detailed here in Adelaide and we are known for this research around the world. We now have the opportunity to continue to lead, internationally, this research because this ... will be a full study about (whether) the course of these standard treatments for heart attacks are actually of benefit to people who have MINOCA.”

Prof Beltrame was able to diagnose Mr Lamming: “Tim’s case provides inspiration to find more treatments for people like him.”

Mr Lamming, 48, says his first heart attack came out of the blue in December 2012 and was seriously scary. “I was working for Bunnings and doing some heavy lifting ... and it was a hot day,” Mr Lamming says. “I just started to feel off and after probably 10 or 15 minutes I was an absolute sea of perspiration. I went upstairs to sit down ... and that’s when the chest pain started to come on. My boss walked past he took one look at me and said ‘I think you need to go to hospital’.

On the way down North Tce, I arrested in the back of an ambulance and they had to give me a thump on the chest to get me going again.

Over the next two years, Mr Lamming suffered severe unexplained chest pain on average every 12 weeks, forcing him to quit work and become almost housebound. The medications he was prescribed also gave him severe headaches and even migraines. Finally, in 2015 he was put in touch with Prof Beltrame who diagnosed him with MINOCA. Mr Lamming did not qualify for Prof Beltrame’s research work but is desperately hoping it yields a better treatment.

“It’s really important for me that he succeeds and that he’s able to do the research into this condition. It’s not a common condition and, while Prof Beltrame ... has been able to find a combination of medication that’s at least stopped me from having heart attacks, it hasn’t been able to stop me from having chest pain and that’s the biggest impact on my life,” he says.

“It’s really important that funding for research continues so that it can help people like me try and return to some sense of normality. Just to be able to do the daily things that a lot of people take for granted.”

PROFESSOR GUY MADDERN

Prof Maddern, a liver surgeon and Director of Surgery for the Central Adelaide Local Health Network, has spent much of his life working to repair people’s livers — often from the ravages of cancer — and finding better ways to help treat his patients. About 28,000 Australians are diagnosed with metastatic liver cancer each year.

“THRF has been fantastic for supporting research generally but certainly in surgery we’ve been beneficiaries of their initiatives,” he says.

“The sorts of projects that we’ve been involved with have been around particularly detecting cancers, so we are trying to detect in patients whether the cancer is likely to have spread at a very early stage long before scans or normal blood tests would pick this up. That’s been an area we’re working on and quite successfully.”

The work has looked at finding new ways of destroying tumours instead of surgically removing them. “We actually put probes in to destroy them by all sorts of means — some of them are thermal, where you heat them, some of them are electric, where you create an electrical imbalance which destroys them, and others are a combination,” he says.

“We are now able to operate on patients, for example with liver cancers, that would’ve been considered inoperable before.”

Prof Maddern says THRF supports research efforts by funding staff time but also with new equipment used to evaluate and analyse samples from patients.

The research is crucial, he says, because even if new technologies or treatments do not work out, the results go to inform the next round of experimentation that may lead to a break through: “In the long run (it) is helping our community.”

THE HOSPITAL RESEARCH HOME LOTTERY

To date, THRF, especially through its highly-popular Home Lottery, has provided more than $5.5 million to fund research and patient care at the RAH, including the Clinical Trials Centre. In 2017, it provided more than $12 million in funding to South Australia’s hospitals for lifesaving medical research and patient care.

The latest Home Lottery offers the biggest Grand Prize to date, valued at more than $2.8 million. The fully-furnished Scott Salisbury Home at Henley Beach is just minutes from the foreshore. This home has boutique resort stylings AND comes with $1 million in cash. At least 13,705 prizes will be given away, including luxury vehicles, worldwide holidays, electrical goods and more.

Whether you win or lose, the money raised will continue to support lifesaving medical research and patient care through THRF, which also opened its own office at the RAH in October 2017. The hub will allow the public easy access to information on the work of THRF and a place to make donations and buy tickets in each new lottery.

Funds totalling $750,000 have also recently been announced for another three RAH research projects, with more funding rounds soon to be announced.

Prof Beltrame explains the new research grants at the RAH: “The first is to embark on a (team) study of whether artificial sweeteners can perhaps cause diabetes rather than preventing diabetes led by Professor Chris Rayner. Professor Marianne Chapman, a specialist from the ICU, will investigate how much protein we have to give patients who are on a long-stay in intensive care. This will have an important impact on their outcomes. The third grant has been awarded to Professor Prashanthan Sanders, one of my cardiology colleagues, who continues his internationally renowned research into atrial fibrillation (an irregular, often rapid heart rate that causes poor blood flow). He’s now looking at how best to implement this in the hospital system.

“This is very exciting because the outstanding research that’s been done at the RAH for many years can now be further advanced with these additional funds.”

THRF chief executive Paul Flynn says: “We exist to save lives. Our work is only possible thanks to the support of our donors and ticket buyers in the Hospital Research Home Lottery. Thank you to the South Australian community for their ongoing support.”

‘I’m Afghan and feel pride every time I put on my Aussie uniform’

Kbora Ali’s dad was rescued from the Timor Sea by the Royal Australian Navy on his journey to escape persecution. Now, she is committed to serving the country that saved her family.

Inside the intensely private world of art dealer Philip Bacon

Wickedly funny, understated, control freak. Philip Bacon is widely recognised as Australia’s leading art dealer but there’s a lot about him the public doesn’t know.

ANTRACIT LLC

• / BUSINESS DIRECTORY
• / MANAGEMENT OF COMPANIES AND ENTERPRISES
• / RUSSIAN FEDERATION
• / MOSCOW REGION
• / ELEKTROSTAL
• / ANTRACIT LLC
• Ilya Viktorovich Kirkin Director-General

Dynamic search and list-building capabilities

Real-time trigger alerts

Comprehensive company profiles

Valuable research and technology reports

• Corporate Family